(Q51553616)
Statements
Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance. (English)
1 reference
Cusi K
1 reference
DeFronzo R
1 reference
1 September 2000
1 reference
85
1 reference
9
1 reference
3077-3084
1 reference